What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Parkinson's disease
Nir Giladi focuses on Physical medicine and rehabilitation, Physical therapy, Parkinson's disease, Gait and Gait.
The various areas that Nir Giladi examines in his Physical medicine and rehabilitation study include Injury prevention, Neurology and Dual tasking, Cognition.
His Physical therapy research includes themes of Quality of life, Rhythm and STRIDE.
His Parkinson's disease research incorporates themes from Rating scale and Central nervous system disease, Degenerative disease.
His work on Gait disorders as part of general Gait study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His studies in Gait integrate themes in fields like Randomized controlled trial, Movement disorders, Severity of illness and Fall risk.
His most cited work include:
- The role of executive function and attention in gait (1263 citations)
- The role of executive function and attention in gait (1263 citations)
- Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease (1243 citations)
What are the main themes of his work throughout his whole career to date?
Nir Giladi spends much of his time researching Parkinson's disease, Physical medicine and rehabilitation, Physical therapy, Cognition and Disease.
His research integrates issues of Neurology and Central nervous system disease in his study of Parkinson's disease.
His Physical medicine and rehabilitation research focuses on Gait, Gait, STRIDE, Gait Disturbance and Balance.
He has researched Physical therapy in several fields, including Fall risk, Quality of life, Movement disorders and Rating scale.
His Cognition study combines topics in areas such as Developmental psychology and Cognitive decline.
His Disease research is multidisciplinary, relying on both Mutation, Psychiatry and Odds ratio.
He most often published in these fields:
- Parkinson's disease (66.93%)
- Physical medicine and rehabilitation (53.35%)
- Physical therapy (40.72%)
What were the highlights of his more recent work (between 2016-2021)?
- Parkinson's disease (66.93%)
- Physical medicine and rehabilitation (53.35%)
- Cognition (30.27%)
In recent papers he was focusing on the following fields of study:
His main research concerns Parkinson's disease, Physical medicine and rehabilitation, Cognition, Disease and Internal medicine.
His work on LRRK2 is typically connected to In patient as part of general Parkinson's disease study, connecting several disciplines of science.
His work on Gait, Gait, Balance and STRIDE as part of general Physical medicine and rehabilitation research is frequently linked to Wearable technology, bridging the gap between disciplines.
His Cognition research is multidisciplinary, incorporating elements of Physical therapy and Cognitive decline.
Nir Giladi interconnects Quality of life and Dysphagia in the investigation of issues within Physical therapy.
His Internal medicine research integrates issues from Gastroenterology, Oncology and Cardiology.
Between 2016 and 2021, his most popular works were:
- Effects of aging on prefrontal brain activation during challenging walking conditions (77 citations)
- Gait impairments in Parkinson's disease. (75 citations)
- Gait impairments in Parkinson's disease. (75 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cognition
His primary areas of study are Parkinson's disease, Physical medicine and rehabilitation, Cognition, Disease and Internal medicine.
His work deals with themes such as Clinical trial, Gait, Randomized controlled trial, Neurology and Rigidity, which intersect with Parkinson's disease.
His research in the fields of Gait, Dual task walking and Gait speed overlaps with other disciplines such as In patient.
His research on Cognition often connects related areas such as Physical therapy.
His Disease study integrates concerns from other disciplines, such as Neuroplasticity, Pharmacological therapy, Oncology and Genotype.
He focuses mostly in the field of Internal medicine, narrowing it down to matters related to Rating scale and, in some cases, Montreal Cognitive Assessment, Dopamine transporter, Confounding, Putamen and Cross-sectional study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
